1H-Pyrazolo[3,4-b]pyridine-3-carbaldehyde, 95.0%, 500mg

(1-Benzyl-piperidin-4-yl)-N-methyl-amine, 97.0%, 250mg

2-(5-(p-Tolyl)-1,3,4-oxadiazol-2-yl)acetic acid, 98%, 250mg

1-(7-Amino-5-fluoro-indolin-1-yl)ethanone, 98%, 500mg

3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 1g

methyl amino(2-chlorophenyl)acetate hydrochloride, 95.0%, 5g

Fmoc-(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid, 97%, 1g

1-(5-Bromo-2-methoxyphenyl)-2,2,2-trifluoroethanone, 1g

Benzoic acid benzyl ester, min. 99%, for synthesis, 2.5 l, glass packaging

3-Chloro-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride, 98%, 250mg

Vinyltris(trimethylsiloxy)silane, 98%, 25g

(4-aminobicyclo[2.2.2]octan-1-yl)methanol hydrochloride, 95.0%, 250mg

N-(2,2,2-trifluoroethyl)pyridin-2-amine, 95.0%, 5g